# Neotame Market

> Neotame Market Size, Share, Industry Trend & Analysis Research Report By Application (Food and Beverage (Bakery Products, Confectionery, Dairy Products, Beverages, Other Food and Beverage Products), Pharmaceuticals, Other Applications), By Region (North America, Europe, Asia Pacific, Rest of the World) - Forecast to 2035

- **Forecast Period:** 2026-2035
- **CAGR:** 3.70%
- **2025:** USD 84.6 Million
- **2035:** USD 121.7 Million
- **Key Players:** Changzhou Niutang Chemical Plant Co., Ltd., Beijing Vitasweet Co., Ltd., Hangzhou Gengyang Chemical Materials Co., Ltd., Tate & Lyle PLC, Ingredion Incorporated, Cargill, Incorporated, Ajinomoto Co., Inc., JK Sucralose Inc.

**Report ID:** MRFR/FnB/23192-HCR · **Pages:** 128 · **Author:** Varsha More · **Last Updated:** October 13, 2026

**URL:** https://www.marketresearchfuture.com/reports/neotame-market-24818

---

## Market Summary

## Neotame Market Summary

The global neotame market was valued at USD 84.6 million in 2025 and is projected to reach USD 87.7 million in 2026, rising to USD 121.7 million by 2035 at a CAGR of 3.70% over 2026–2035. Two forces anchor this trajectory. Sugar-sweetened beverage taxes now operate in more than 100 jurisdictions [4], and front-of-pack warning regimes such as Mexico's NOM-051 have pushed formulators to cut added sugar at scale [13]. Neotame, roughly 7,000 to 13,000 times sweeter than sucrose, lets manufacturers remove sugar at a very low cost per unit of sweetness.

Formulation practice is shifting away from single-sweetener systems toward blends. Legacy aspartame and saccharin formulas are being replaced by multi-component systems in which neotame masks the bitterness of stevia glycosides or extends sweetness in heat-processed goods. Regulatory breadth supports this shift: the US FDA approved neotame as a general-purpose sweetener in 2002 [5], and the EU authorised it as E961 under Directive 2009/163/EU [6]. Within the wider family of high-intensity sweeteners, neotame stands out for thermal stability and negligible caloric load.

North America leads with a 36.8% share in 2025, supported by mature beverage and tabletop channels. Asia Pacific is the fastest-growing region at a 4.9% CAGR, driven by Chinese production capacity and rising diabetes prevalence in India [18]. Europe ranks second at USD 23.2 million, sustained by bakery reformulation. The next decade will reward suppliers that pair low-cost synthesis with formulation support.

## Key Report Takeaways

### • By Application

- Food and Beverage accounts for 82.4% of the neotame market in 2025, led by beverage and bakery reformulation
- Pharmaceuticals is the fastest-expanding application at a 4.3% CAGR through 2035, supported by pediatric syrup and chewable tablet demand.
- Other Applications, including animal feed palatants, are valued at USD 4.6 million in 2025

### • By Region

- North America holds 36.8% of the neotame market, anchored by the United States beverage sector
- Asia Pacific posts the highest regional growth at a 4.9% CAGR, backed by China's production base and India's demand expansion
- Europe generates USD 23.2 million in 2025, with bakery applications as the main demand pool

## Market Size and Forecast (2021–2035)

Market Research Future built the neotame market estimates through a bottom-up model that aggregates production volumes from major Chinese and Western manufacturers, converts them to value at average realised selling prices, and validates the totals against end-use consumption in beverages, bakery, confectionery, dairy, and pharmaceutical formulations. Trade data and company disclosures [14][15][16] were triangulated with regulatory usage limits to cap theoretical demand.

## Market Drivers

## Driver Impact Analysis

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Sugar taxes and front-of-pack labelling | +0.9% | Europe, Latin America, Asia Pacific | Medium term (2–4 yr) | [4][12][13] |
| Rising diabetes and obesity prevalence | +0.8% | Global, strongest in Asia Pacific | Long term (≥4 yr) | [2] |
| Cost-in-use advantage per sweetness unit | +0.6% | Global | Short term (≤2 yr) | [8] |
| Broad regulatory approvals | +0.5% | Global | Medium term (2–4 yr) | [5][6] |
| Blended sweetener systems in beverages | +0.5% | North America, Asia Pacific | Short term (≤2 yr) | [14][15] |
| Heat stability for bakery applications | +0.4% | Europe, North America | Medium term (2–4 yr) | [7] |
| Pharmaceutical formulation demand | +0.3% | North America, Europe, India | Long term (≥4 yr) | [10] |

### Sugar Taxes and Front-of-Pack Labelling

Fiscal and labelling policy is the single strongest demand lever. WHO reports that more than 100 countries and territories now tax sugar-sweetened beverages [4]. The UK Soft Drinks Industry Levy charges 24p per litre on drinks above 8g sugar per 100ml, and most producers reformulated below the threshold rather than pay [12]. Mexico's 2020 warning-label rule had a similar effect [13]. Each reformulation wave creates demand for potent, inexpensive sweeteners such as neotame.

### Rising Diabetes and Obesity Prevalence

The IDF Diabetes Atlas estimates 589 million adults lived with diabetes in 2024, a figure projected to reach 853 million by 2050 . WHO counts 890 million adults living with obesity [2]. These numbers translate directly into consumer demand for reduced-sugar foods and into clinical guidance that favours non-nutritive sweetening. Asia Pacific carries the largest absolute patient pool, which explains its above-average growth rate.

### Cost-in-Use Advantage

Neotame has one of the lowest costs per sweetness-equivalent among approved severe sweeteners because of its extraordinary potency, which requires just milligrams per liter to mimic sucrose sweetness. An acceptable daily intake of 0–2 mg per kg body weight, comfortably above average exposure, was established by JECFA's study [8]. Compared to sugar-only recipes, this advantage allows price-conscious beverage bottlers in emerging regions to reduce ingredient prices by double digits.

### Broad Regulatory Approvals

Neotame holds approvals from the US FDA (21 CFR 172.829) [5], the EU as E961 [6], and Codex under INS 961 . China's updated GB 2760-2024 standard, effective February 2025, retains neotame across numerous food categories . This approval breadth lets multinational formulators deploy a single sweetener system across regions, which shortens product development cycles and lowers regulatory dossier costs for each launch in the neotame market.

### Blended Sweetener Systems in Beverages

Beverage companies increasingly combine neotame with stevia, sucralose, or acesulfame-K to round out sweetness and suppress off-notes. Neotame at parts-per-million levels can reduce the lingering bitterness of steviol glycosides, improving taste scores in zero-sugar drinks. Ingredient majors including Tate & Lyle and Ingredion have built sweetener-blending capability into their solutions businesses [14][15], which expands neotame's addressable volume.

### Heat Stability for Bakery Applications

Unlike aspartame, neotame tolerates baking temperatures with limited degradation, making it suitable for biscuits, cakes, and fillings. EFSA's 2007 safety opinion supported use across a broad category list including fine bakery wares [7]. European bakers facing reformulation targets value this stability because it removes the need for encapsulation. Bakery Products already account for 21.6% of food and beverage demand.

### Pharmaceutical Formulation Demand

Neotame is used by pharmaceutical formulators to cover up bitter active compounds in orally disintegrating tablets, syrups, and chewables. Excipient load is kept to a minimum by its low dose requirement, which is important for pediatric dosage forms. Demand is increasing due to India's developing generic medication market, which is regulated by the FSSAI and drug regulators [10]. With a 4.3% CAGR, this application is expanding more quickly than the market as a whole.

## Restraints

## Restraints Impact Analysis

The negative impact percentages below are directional and partly offset one another. They indicate relative drag rather than an exact subtraction from the market CAGR.

| Restraint | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| WHO guidance and safety perception | −0.6% | Global | Medium term (2–4 yr) | [3][11] |
| Clean-label shift toward plant-based sweeteners | −0.5% | North America, Europe | Long term (≥4 yr) | [14] |
| Supply concentration and price erosion | −0.3% | Global | Short term (≤2 yr) | [20] |
| Uneven usage limits and approval gaps | −0.3% | Rest of the World, Asia Pacific | Medium term (2–4 yr) |  |
| Sensory limitations at higher doses | −0.2% | Global | Short term (≤2 yr) | [7] |

### WHO Guidance and Safety Perception

WHO's May 2023 guideline advised against non-sugar sweeteners for weight control [3]. Two months later, IARC classified aspartame as possibly carcinogenic (Group 2B) [11]. Neotame is an aspartame derivative, and some consumers conflate the two. Brand owners in premium segments have responded by de-emphasising synthetic sweeteners on labels, which slows neotame adoption in the neotame market's higher-margin channels.

### Clean-Label Shift Toward Plant-Based Sweeteners

Monk fruit and stevia have a "natural" positioning that is unmatched by artificial sweeteners. Plant-derived sweetener portfolios are expanding more quickly than synthetic lines, according to major ingredient suppliers [14]. Retailer private-label criteria in Western Europe and North America are progressively excluding synthetic choices. By acting as a flavor modifier in stevia mixes, neotame partially counteracts this.

### Supply Concentration and Price Erosion

Most of the world's neotame capacity is produced in China. Even as volumes increase, market value is being compressed due to ongoing price pressure brought on by their competition. Supply might be rapidly tightened by any export disruption or environmental-compliance stoppage in Jiangsu or Shandong provinces. Outside of China, buyers have few other options.

### Uneven Usage Limits and Approval Gaps

Although Codex lists neotame under INS 961 , national adoption varies. Several African and Middle Eastern markets have restrictive category lists or slow approval processes. Usage limits also differ by product category between jurisdictions, forcing multinational brands to maintain separate formulations and limiting economies of scale.

### Sensory Limitations at Higher Doses

At higher concentrations, neotame can exhibit delayed sweetness onset and a lingering aftertaste. EFSA's assessment noted flavour-enhancing properties that alter product profiles at low doses [7]. Formulators therefore rarely use neotame as a sole sweetener, which caps its share of the total sweetening system in many products.

## Opportunities

## Neotame Market Opportunities

### Emerging-Market Beverage Reformulation

India, Southeast Asia, and Africa represent the largest untapped volume opportunity. India alone has an estimated 101 million people living with diabetes [18], and its packaged beverage sector is expanding rapidly. Low cost per sweetness unit makes neotame attractive to regional bottlers who cannot absorb stevia's price premium. Suppliers that secure local distribution and regulatory registration early stand to gain share in the neotame market.

### Stevia-Neotame Taste Modulation Systems

Clean-label pressure creates an indirect opening. Neotame used at sub-sweetening levels can improve the taste of stevia-led formulations while appearing as a minor ingredient. Suppliers that develop pre-blended, application-specific systems for carbonated drinks, flavoured dairy, and ready-to-drink teas can capture value beyond commodity neotame pricing.

### Formulation-as-a-Service Business Models

Companies that offer ingredients are switching from selling kilograms to selling results. Technical depth is rewarded through formulation-as-a-service contracts, where the supplier provides a verified sugar-reduction recipe and receives payments based on launch volume. Under this strategy, digital formulation libraries and sensory-panel data become monetizable assets that provide recurring revenue instead of spot sales.

### Pediatric and Geriatric Pharmaceutical Formats

As the population ages and pediatric medicine labeling regulations tighten, there is an increasing demand for palatable oral liquids and oral disintegrating tablets. These formats work well with Neotame's low dose and stability. Excipient-grade neotame can be obtained directly from contract development organizations in Europe and India.

### Animal Feed Palatants

Neotame is used as a sweetening palatant in piglet and calf feed to improve intake during weaning. Global pork production, concentrated in China, the EU, and the United States, provides a large addressable base [21]. This channel sits within Other Applications and remains under-penetrated outside East Asia.

## Future Outlook

## Neotame Market Future Outlook

### Policy-Led Reformulation Becomes Permanent

Sugar reduction is shifting from voluntary pledges to binding fiscal and labelling rules. WHO's tracking shows steady growth in jurisdictions taxing sugary drinks [4], and each new levy triggers a reformulation cycle. Through 2035, the neotame market will track policy calendars closely, with step changes in demand following tax introductions in large emerging economies.

### AI-Assisted Sweetener Blending

Formulators are adopting machine-learning tools that predict sensory outcomes from ingredient combinations, cutting development time. These tools favour sweeteners with well-characterised taste curves and synergy data. Neotame, used in small doses as a modifier, benefits when its interaction data is built into digital formulation libraries maintained by ingredient majors [15].

### Supply Chain Regionalisation

Concentration of synthesis capacity in China is a known risk for Western buyers. Expect dual-sourcing mandates, safety-stock policies, and possible capacity additions in India or Southeast Asia. USDA projections of tight global sugar balances [20] reinforce interest in reliable supply of sugar substitutes that can buffer sugar price volatility.

### Sustainability Accounting per Sweetness Unit

Scope 3 emissions reporting is pushing food companies to measure the footprint of every ingredient. Because neotame delivers sucrose-equivalent sweetness at a tiny fraction of the mass, its transport and land-use footprint per sweetness unit is very low. OECD-FAO outlooks highlight the land and water intensity of sugar crops [21], a comparison that suppliers can use in sustainability-focused procurement.

## Segment Insights

## Neotame Market Segmentation

The neotame market is segmented by application and geography. Geography is covered in Section 7; this section analyses application segments and the food and beverage sub-segments.

### By Application

| Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Food and Beverage | 82.4% share | Sugar-reduction mandates in drinks and bakery |
| Pharmaceuticals | 4.3% CAGR | Taste masking in pediatric and oral dosage forms |
| Other Applications | USD 4.6 Million | Animal feed palatants and oral-care products |

Food and Beverage dominates the neotame market because beverage and bakery manufacturers consume the bulk of global output. Pharmaceuticals is the fastest-growing application as generic-drug producers in India and Europe replace bulkier sweetening excipients with low-dose options. Other applications cover animal feed palatants, toothpaste, and mouthwash, where neotame improves palatability without adding cariogenic sugar. This group remains small but offers stable, specification-driven demand.

| Food and Beverage Sub-Segment | Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Bakery Products | 21.6% share of Food and Beverage | Heat stability during baking |
| Confectionery | USD 14.9 Million | Sugar-free chewing gum and candy |
| Dairy Products | 11.3% share of Food and Beverage | Flavoured milk and yoghurt reformulation |
| Beverages | 4.1% CAGR | Zero-sugar carbonated and powdered drinks |
| Other Food and Beverage Products | 3.8% CAGR | Tabletop sweeteners, sauces, and snacks |

Within Food and Beverage, Beverages is the largest and fastest-growing sub-segment, driven by levy-induced reformulation of carbonated and powdered drinks. Bakery Products holds a substantial share because neotame survives oven temperatures that degrade aspartame. Confectionery relies on neotame for sugar-free gum, where long-lasting sweetness matters. Dairy Products and Other Food and Beverage Products, including tabletop sachets and sauces, round out demand in the neotame market.

## Regional Market Share Analysis

## Regional Market Share Analysis

| Region | Metric (2025) | Primary Investment Themes |
| --- | --- | --- |
| North America | 36.8% share | Zero-sugar beverages, tabletop blends, pharmaceutical excipients |
| Europe | USD 23.2 Million | Bakery reformulation, levy-driven drink reformulation |
| Asia Pacific | 4.9% CAGR | Chinese production scale, Indian beverage growth |
| Rest of the World | 8.9% share | Sugar taxes in Latin America, feed applications |
| Total | USD 84.6 Million | — |

North America leads the neotame market, while Asia Pacific grows fastest on the back of production capacity and demand expansion.

### North America

| Country | Metric | Key Driver |
| --- | --- | --- |
| United States | 78.5% share of region | Beverage reformulation and FDA general-purpose approval |
| Canada | USD 3.4 Million | Health Canada front-of-pack labelling |
| Mexico | 4.1% CAGR | IEPS beverage tax and warning labels |
| Rest of North America | 3.6% share of region | Imported reduced-sugar products |

The United States dominates regional demand because neotame has held general-purpose approval since 2002 [5], and its negligible phenylalanine content means US products need no PKU warning. The FDA's December 2024 final rule updating the "healthy" claim set added-sugar limits that push reformulation further. Mexico grows fastest in the region on the strength of its beverage tax and mandatory warning labels [13], which make the neotame market there highly responsive to cost-efficient sweetening.

### Europe

| Country | Metric | Key Driver |
| --- | --- | --- |
| United Kingdom | 17.2% share of region | Soft Drinks Industry Levy |
| Germany | USD 5.1 Million | Bakery and confectionery reformulation |
| France | 3.0% CAGR | Nutri-Score labelling pressure |
| Russia | 9.4% share of region | Domestic beverage cost optimisation |
| Italy | USD 2.3 Million | Confectionery and dairy demand |
| Spain | 3.3% CAGR | Regional sugar-drink taxation |
| Rest of Europe | 24.1% share of region | Nordic and Central European reformulation |

Europe's demand centres on bakery, where neotame's heat stability is a clear technical advantage [7]. The UK levy has already pushed most soft drinks below taxable thresholds [12], and a 2025 government consultation on strengthening it signals further reformulation. Germany leads continental consumption through its large bakery and confectionery industry, while Nutri-Score adoption in France and neighbouring markets rewards products with lower sugar content.

### Asia Pacific

| Country | Metric | Key Driver |
| --- | --- | --- |
| China | 41.5% share of region | Production scale and GB 2760-2024 approval |
| India | 6.2% CAGR | Diabetes prevalence and beverage growth |
| Japan | USD 4.1 Million | Functional beverages and ageing population |
| Australia | 6.8% share of region | Health Star Rating reformulation |
| Rest of Asia-Pacific | 4.6% CAGR | Southeast Asian sugar taxes |

China is both the region's largest consumer and the world's principal neotame producer. GB 2760-2024, effective February 2025, confirms permitted categories and gives domestic manufacturers regulatory certainty . India is the fastest-growing country in the neotame market as its diabetes burden [18] meets an expanding packaged-beverage sector. Sugar-drink taxes in Thailand, the Philippines, and Malaysia support demand across the Rest of Asia-Pacific.

### Rest of the World

| Country | Metric | Key Driver |
| --- | --- | --- |
| South America | 48.2% share of region | Brazilian and Chilean labelling rules |
| Africa | 4.4% CAGR | South Africa Health Promotion Levy |
| Middle-East | USD 2.2 Million | Gulf excise taxes on sugary drinks |

South America leads this grouping, with Chile's warning-label law and Brazil's front-of-pack rules driving reformulation. Africa grows quickest from a small base, helped by South Africa's Health Promotion Levy. Gulf Cooperation Council states apply a 50% excise tax on sugar-sweetened drinks [4], encouraging Middle East bottlers to adopt potent, low-cost sweetening systems.

## Competitive Benchmarking

## Competitive Benchmarking

The neotame market has low concentration. The top five producers hold an estimated 40–50% of revenue, and the Herfindahl-Hirschman Index sits near 700–900, indicating a fragmented structure. Chinese manufacturers dominate synthesis capacity, while Western ingredient majors compete through blending, application support, and distribution reach.

| Company | Est. Revenue Share Range | Key Offerings for Neotame Market | Strategic Positioning |
| --- | --- | --- | --- |
| Changzhou Niutang Chemical Plant Co., Ltd. | ~14–18% | Bulk neotame, sucralose, acesulfame-K | Cost leader with large-scale synthesis |
| The NutraSweet Company | ~10–13% | Neotame originator brand, sweetener blends | Brand heritage and regulatory dossiers |
| Beijing Vitasweet Co., Ltd. | ~7–10% | Neotame, sweetener blends | Export-focused blending specialist |
| Hangzhou Gengyang Chemical Materials Co., Ltd. | ~5–8% | Food-grade and pharma-grade neotame | Price-competitive supplier to Asia |
| Tate & Lyle PLC | ~4–7% | Sweetener systems, formulation services | Solutions-led sugar-reduction partner |
| Ingredion Incorporated | ~3–6% | Stevia-led blends with modifiers | Clean-label taste modulation |
| Cargill, Incorporated | ~3–5% | Sweetener blends for beverages | Global distribution and beverage reach |
| Ajinomoto Co., Inc. | ~2–4% | Amino-acid-based sweeteners | Peptide sweetener chemistry expertise |
| JK Sucralose Inc. | ~2–4% | Intense sweetener portfolio | Diversified Chinese producer |
| Foodchem International Corporation | ~2–3% | Distribution of neotame and blends | Trading and logistics network |

## Recent News & Developments

## Recent News & Developments

- WHO (May 2023): Issued guidance advising against non-sugar sweeteners for weight control, prompting brand owners to review sweetener positioning and labelling [3]
- IARC and JECFA (July 2023): IARC classified aspartame as Group 2B while JECFA retained its acceptable daily intake, raising scrutiny across peptide-based sweeteners including neotame [11]
- China NHC and SAMR (March 2024): Published GB 2760-2024, effective February 2025, confirming neotame usage categories for the world's largest producing country
- Tate & Lyle (November 2024): Completed its acquisition of CP Kelco for about USD 1.8 billion, broadening its texture and sweetening solutions for sugar-reduced products [22]
- US FDA (December 2024): Finalised the updated "healthy" nutrient content claim with added-sugar limits, encouraging reformulation with potent sweeteners [5]
- International Diabetes Federation (April 2025): Released its 11th Diabetes Atlas reporting 589 million adults with diabetes, reinforcing long-term demand for sugar reduction
- UK Government (April 2025): Opened a consultation on strengthening the Soft Drinks Industry Levy, signalling a further reformulation wave in the neotame market [12]

## Report Scope

| Parameter | Details |
| --- | --- |
| Market Scope | Covers neotame produced and sold for food and beverage, pharmaceutical, and other applications through direct and distributor channels worldwide |
| Study Period | 2021–2035 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2035 |
| Market Size in 2025 | USD 84.6 Million |
| Market Size in 2035 | USD 121.7 Million |
| CAGR | 3.70% (2026–2035) |
| Fastest Growing Segments | Pharmaceuticals (4.3% CAGR); Beverages (4.1% CAGR); Other Food and Beverage Products (3.8% CAGR) |
| Regions Covered | North America, Europe, South America, Asia Pacific, Middle East and Africa and ROW |
| Companies Profiled | Changzhou Niutang Chemical Plant Co., Ltd., The NutraSweet Company, Beijing Vitasweet Co., Ltd., Hangzhou Gengyang Chemical Materials Co., Ltd., Tate & Lyle PLC, Ingredion Incorporated, Cargill, Incorporated, Ajinomoto Co., Inc., JK Sucralose Inc., Foodchem International Corporation |
| Valuation Currency | USD Million |
| Methodology | 350+ primary expert interviews; bottom-up market sizing; top-down validation; data triangulation; scenario-based forecasting; real-time project tracking |

## Frequently Asked Questions

**Q: How does neotame compare with sucralose for heat-processed products in the neotame market?**
A: Both tolerate baking temperatures, but neotame needs far smaller doses for equal sweetness. Sucralose remains preferred where a clean sucrose-like profile matters most, while neotame wins on cost-in-use [7].

**Q: Do products sweetened with neotame require a phenylketonuria warning?**
A: No, not in the United States. Neotame releases only negligible phenylalanine at approved use levels, so the FDA does not require the PKU statement mandated for aspartame [5].

**Q: What should buyers check when qualifying a new supplier in the neotame market?**
A: Request purity certificates meeting JECFA or FCC specifications, residual-solvent data, and audit reports. Dual-sourcing across at least two plants reduces exposure to production shutdowns [8].

**Q: Can neotame support halal and kosher product certification?**
A: Yes, it is synthesised without animal-derived inputs. Certification depends on each manufacturer's plant audit, so buyers should verify current certificates rather than assume compliance.

**Q: Which emerging use case could open new demand in the neotame market?**
A: Oral-care and nicotine-free pouch products are promising. Their small formats need intense sweetness with minimal ingredient mass, which suits neotame's potency [19].

**Q: How long does a typical reformulation project using neotame take?**
A: Beverage reformulations usually take six to twelve months, including sensory testing and shelf-life trials. Bakery projects often run longer because thermal behaviour must be validated across product formats.

**Q: Is neotame suitable for organic-certified products?**
A: No. Organic standards in the United States and EU exclude synthetic sweeteners, so organic brands rely on plant-derived options instead.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/neotame-market-24818*